Nuwellis (NUWE) to Release Quarterly Earnings on Tuesday

Nuwellis (NASDAQ:NUWE) is anticipated to release its results before the market opens on Tuesday, March 10th. Analysts expect Nuwellis to post earnings of ($1.56) per share and revenue of $2.31 million for the quarter.

Nuwellis Price Performance

Shares of NASDAQ:NUWE opened at $1.43 on Friday. The company has a market capitalization of $2.67 million, a price-to-earnings ratio of -0.01 and a beta of -0.03. The business’s 50-day moving average is $2.18 and its 200-day moving average is $2.91. Nuwellis has a 1 year low of $1.40 and a 1 year high of $56.28.

Wall Street Analyst Weigh In

NUWE has been the subject of a number of research analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nuwellis in a report on Monday, December 29th. Wall Street Zen cut Nuwellis from a “hold” rating to a “sell” rating in a report on Saturday, November 15th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold”.

About Nuwellis

Nuwellis (NASDAQ:NUWE) is a medical technology company focused on developing therapies and devices to manage fluid overload in patients with cardiorenal and cardiovascular conditions. The company’s core business revolves around designing, manufacturing and marketing the Aquadex™ FlexFlow® System, a gentle ultrafiltration device intended to remove excess fluid in patients with acute decompensated heart failure, cardiorenal syndrome and other fluid‐overload disorders. By providing an alternative to traditional diuretic therapy, Nuwellis aims to improve patient outcomes and reduce hospital stays.

The Aquadex FlexFlow System operates by drawing blood through a low‐shear filter and returning it to the patient, allowing precise control of fluid removal at the bedside outside of an intensive care setting.